ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 812 filers reported holding ISHARES TR in Q3 2023. The put-call ratio across all filers is 3.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,949 | -3.7% | 547 | 0.0% | 0.06% | +7.7% |
| Q2 2023 | $69,505 | -1.7% | 547 | 0.0% | 0.05% | -5.5% |
| Q1 2023 | $70,710 | -1.6% | 547 | 0.0% | 0.06% | +1.9% |
| Q4 2022 | $71,876 | +12.3% | 547 | 0.0% | 0.05% | -1.8% |
| Q3 2022 | $64,000 | 0.0% | 547 | 0.0% | 0.06% | +7.8% |
| Q2 2022 | $64,000 | -9.9% | 547 | 0.0% | 0.05% | +8.5% |
| Q1 2022 | $71,000 | -15.5% | 547 | 0.0% | 0.05% | -11.3% |
| Q4 2021 | $84,000 | -5.6% | 547 | 0.0% | 0.05% | -19.7% |
| Q3 2021 | $89,000 | -1.1% | 547 | 0.0% | 0.07% | 0.0% |
| Q2 2021 | $90,000 | -1.1% | 547 | -9.3% | 0.07% | -9.6% |
| Q1 2021 | $91,000 | 0.0% | 603 | 0.0% | 0.07% | -6.4% |
| Q4 2020 | $91,000 | +11.0% | 603 | 0.0% | 0.08% | +5.4% |
| Q3 2020 | $82,000 | 0.0% | 603 | 0.0% | 0.07% | -17.8% |
| Q2 2020 | $82,000 | +26.2% | 603 | 0.0% | 0.09% | +15.4% |
| Q1 2020 | $65,000 | -9.7% | 603 | 0.0% | 0.08% | +1.3% |
| Q4 2019 | $72,000 | – | 603 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elliott Investment Management L.P. | 4,617,600 | $564,686,304 | 4.37% |
| BOULDER HILL CAPITAL MANAGEMENT LP | 57,250 | $7,001,103 | 4.35% |
| DAFNA Capital Management LLC | 102,500 | $12,534,725 | 3.90% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,306,775 | 3.58% |
| Rye Brook Capital LLC | 40,900 | $5,002 | 3.56% |
| Bronte Capital Management Pty Ltd. | 283,229 | $34,636,074 | 3.49% |
| FWL INVESTMENT MANAGEMENT, LLC | 39,504 | $4,830,944 | 3.24% |
| Alpha Family Trust | 34,568 | $4,227,321 | 3.22% |
| HARBOUR INVESTMENT MANAGEMENT LLC | 40,720 | $4,985,830 | 2.85% |
| CUMBERLAND ADVISORS INC | 51,490 | $6,296,712 | 2.79% |